Education
About Us
Working with TipRanks
Follow Us
Tourmaline Bio, Inc. (TRML)
:TRML
TRML Analyst Ratings
Hold
1 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TRML Stock 12 Month Forecast
Average Price Target
$47.93
▼(-0.48% Downside)
| Highest Price Target$48.00 | Average Price Target$47.93 | Lowest Price Target$47.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
―
Hold
―
Downgraded
09/10/25
Truist Financial
$63→$48
Hold
-0.33%
Downside
Downgraded
09/10/25
H.C. Wainwright
$50→$48
Hold
-0.33%
Downside
Downgraded
09/10/25
LifeSci Capital
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Guggenheim
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Wedbush
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Chardan Capital
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Jefferies
$64→$47.5
Hold
-1.37%
Downside
Downgraded
09/09/25
Leerink Partners
―
Buy
―
Reiterated
09/02/25
Cantor Fitzgerald
―
Buy
―
Reiterated
04/23/25
Barclays
$50
Buy
3.82%
Upside
Initiated
12/05/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
―
Hold
―
Downgraded
09/10/25
Truist Financial
$63→$48
Hold
-0.33%
Downside
Downgraded
09/10/25
H.C. Wainwright
$50→$48
Hold
-0.33%
Downside
Downgraded
09/10/25
LifeSci Capital
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Guggenheim
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Wedbush
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Chardan Capital
$48
Hold
-0.33%
Downside
Downgraded
09/09/25
Jefferies
$64→$47.5
Hold
-1.37%
Downside
Downgraded
09/09/25
Leerink Partners
―
Buy
―
Reiterated
09/02/25
Cantor Fitzgerald
―
Buy
―
Reiterated
04/23/25
Barclays
$50
Buy
3.82%
Upside
Initiated
12/05/24
Best Analysts Covering Tourmaline Bio
1 Month
xxx
Success Rate
7/11 ratings generated profit
Average Return
+19.37%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +19.37% per trade.
3 Months
xxx
Success Rate
6/11 ratings generated profit
Average Return
+30.02%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +30.02% per trade.
1 Year
Success Rate
9/11 ratings generated profit
Average Return
+68.25%
reiterated a buy rating 29 days ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +68.25% per trade.
2 Years
xxx
Success Rate
11/11 ratings generated profit
Average Return
+132.07%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +132.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TRML Analyst Recommendation Trends
Rating
Apr 25
May 25
Jul 25
Aug 25
Sep 25
Strong Buy
13
21
15
14
6
Buy
3
3
2
1
2
Hold
1
1
0
0
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
25
17
15
18
Each month's total comprises the sum of three months' worth of ratings.
TRML Financial Forecast
TRML Stock Forecast FAQ
What is TRML’s average 12-month price target, according to analysts?
Based on analyst ratings, Tourmaline Bio, Inc.’s 12-month average price target is 47.93.
What is TRML’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TRML, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TRML a Buy, Sell or Hold?
Tourmaline Bio, Inc. has a consensus rating of Hold which is based on 1 buy ratings, 8 hold ratings and 0 sell ratings.
What is Tourmaline Bio, Inc.’s price target?
The average price target for Tourmaline Bio, Inc. is 47.93. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $48.00 ,the lowest forecast is $47.50. The average price target represents -0.48% Decrease from the current price of $48.16.
The highest analyst price target is $48.00 ,the lowest forecast is $47.50. The average price target represents -0.48% Decrease from the current price of $48.16.
What do analysts say about Tourmaline Bio, Inc.?
Tourmaline Bio, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of TRML?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.